Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Radiomics Models to Predict Tumor Response and Pneumonitis in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy.
Journal: Journal of clinical medicine
Published: February 13, 2025
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types.
Journal: Journal for immunotherapy of cancer
Published: January 27, 2024
Redefining Clinical Hyperprogression: The Incidence, Clinical Implications, and Risk Factors of Hyperprogression in Non-Small Cell Lung Cancer Treated with Immunotherapy.
Journal: Clinical lung cancer
Published: October 22, 2023
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 13, 2023
Bilateral orthotopic lung transplantation for the patient with lung-limited invasive mucinous adenocarcinoma: a case-based literature review.
Journal: The oncologist
Published: October 18, 2022
Pericardial Metastasis From Recurrent Squamous Cell Carcinoma of Hypopharynx in a Living Patient.
Journal: Cureus
Published: April 17, 2022
Role of mass spectrometry-based serum proteomics signatures in predicting clinical outcomes and toxicity in patients with cancer treated with immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: January 21, 2022
Metastatic CDK12-Mutated Neuroendocrine Tumor of Lung Showed an Exceptional Response to Olaparib and Paclitaxel.
Journal: JCO precision oncology
Published: January 07, 2022
Artificial Intelligence-based Radiomics in the Era of Immuno-oncology.
Journal: The oncologist
Published: August 05, 2021
Blood transfusions may adversely affect survival outcomes of patients with lung cancer: a systematic review and meta-analysis.
Journal: Translational lung cancer research
Published: May 20, 2021
Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC).
Journal: Cancer immunology, immunotherapy : CII
Published: June 28, 2020
Last Updated: 09/26/2026